Literature DB >> 11168561

Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain.

B J Gibb1, J Garthwaite.   

Abstract

Despite the widespread use of nitric oxide as a signalling molecule in the central nervous system, the molecular makeup of its receptor, soluble guanylyl cyclase (sGC), therein is poorly understood. Accordingly, RT-PCR and in situ hybridization were used to identify sGC subunits expressed in rat brain. In addition to the expected mRNA for alpha 1 and beta1 subunits, message for the beta 2 subunit was detected in the cerebellum at all developmental stages investigated (1--150 days postnatum). The use of degenerate primers allowed the identification of mRNA coding for the rat alpha 2 subunit, which was also expressed at every age studied. All but beta 2 were detected by in situ hybridization in the brains of both 8-day-old and adult rats. The distribution patterns indicated that in some areas, e.g. caudate-putamen and nucleus accumbens, sGC probably exists mainly as the alpha 1 beta 1 heterodimer. In others, e.g. hippocampus and olfactory bulb, alpha 2 beta 1 is likely to be dominant. In the cerebellum, alpha 1 and beta 1 message was strong in the Purkinje cell layer but was not confined to Purkinje cells: smaller cells, presumed to be the Bergmann glia, were also labelled. In contrast, alpha 2 mRNA was concentrated in cerebellar granule cells. Western blotting indicated an excess of alpha 1 over beta 1 protein in the cerebellum, the reverse of what was found in the lung. It is concluded that, in molecular terms, sGC is likely to be more complex and exhibit more regional variation in the brain than previously thought. The functional consequences of this heterogeneity require investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168561     DOI: 10.1046/j.1460-9568.2001.01421.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

Review 1.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus.

Authors:  Alain Burette; Ulrike Zabel; Richard J Weinberg; Harald H H W Schmidt; Juli G Valtschanoff
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

4.  Soluble Guanylyl Cyclases in Invertebrates: Targets for NO and O(2).

Authors:  David B Morton; Anke Vermehren
Journal:  Adv Exp Biol       Date:  2007

Review 5.  NO as a multimodal transmitter in the brain: discovery and current status.

Authors:  John Garthwaite
Journal:  Br J Pharmacol       Date:  2018-12-05       Impact factor: 8.739

6.  NO regulates the strength of synaptic inputs onto hippocampal CA1 neurons via NO-GC1/cGMP signalling.

Authors:  A Neitz; E Mergia; U Neubacher; D Koesling; T Mittmann
Journal:  Pflugers Arch       Date:  2014-07-11       Impact factor: 3.657

Review 7.  NO-cGMP signaling and regenerative medicine involving stem cells.

Authors:  K S Madhusoodanan; Ferid Murad
Journal:  Neurochem Res       Date:  2006-10-18       Impact factor: 3.996

8.  Differential expression of long-term potentiation among identified inhibitory inputs to dopamine neurons.

Authors:  DeNard V Simmons; Alyssa K Petko; Carlos A Paladini
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

9.  Hyperpolarization-activated ion channels as targets for nitric oxide signalling in deep cerebellar nuclei.

Authors:  Gary W Wilson; John Garthwaite
Journal:  Eur J Neurosci       Date:  2010-06-01       Impact factor: 3.386

10.  Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity.

Authors:  Erin J Heckler; Pierre-Antoine Crassous; Padmamalini Baskaran; Annie Beuve
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.